Aug. 22 at 3:43 PM
$AMRN $MXL $AEM $NEM $NOC Amarin remains focused on cardiovascular therapies, MaxLinear benefits from connectivity and semiconductor demand, Agnico Eagle benefits from gold prices and mining operations, Newmont benefits from gold prices and production, and Northrop Grumman benefits from sustained defense spending. I'm watching prescription trends, chip demand, gold prices, production costs, and defense contracts.